• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 S2P 刺突通过不同状态的老化,改变了其免疫原性。

SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity.

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.

出版信息

J Biol Chem. 2021 Oct;297(4):101127. doi: 10.1016/j.jbc.2021.101127. Epub 2021 Aug 27.

DOI:10.1016/j.jbc.2021.101127
PMID:34461095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8393506/
Abstract

The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline "S2P" spike-widely employed for laboratory work and clinical studies-unfolds when stored at 4 °C, physiological pH, as observed by electron microscopy (EM) and differential scanning calorimetry, but that its trimeric, native-like conformation can be reacquired by low pH treatment. When stored for approximately 1 week, this unfolding does not significantly alter antigenic characteristics; however, longer storage diminishes antibody binding, and month-old spike elicits virtually no neutralization in mice despite inducing high ELISA-binding titers. Cryo-EM structures reveal the folded fraction of spike to decrease with aging; however, its structure remains largely similar, although with varying mobility of the receptor-binding domain. Thus, the SARS-CoV-2 spike is susceptible to unfolding, which affects immunogenicity, highlighting the need to monitor its integrity.

摘要

SARS-CoV-2 的刺突蛋白是病毒中和抗体的主要靶点,对于开发针对 COVID-19 的有效疫苗至关重要。在这里,我们证明了预融合稳定的双脯氨酸“S2P”刺突蛋白——广泛用于实验室工作和临床研究——在 4°C 和生理 pH 下会展开,这可以通过电子显微镜 (EM) 和差示扫描量热法观察到,但它的三聚体、天然样构象可以通过低 pH 处理重新获得。储存约 1 周后,这种展开不会显著改变抗原特性;然而,长时间储存会降低抗体结合能力,而且即使诱导出高 ELISA 结合滴度,一个月大的刺突蛋白也几乎不能引起中和作用。冷冻电镜结构显示,随着时间的推移,刺突蛋白的折叠部分减少;然而,尽管受体结合域的流动性不同,其结构仍然大致相似。因此,SARS-CoV-2 的刺突蛋白容易展开,这会影响其免疫原性,强调了需要监测其完整性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/246eefaa06c6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/005d39b8b553/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/aaf6fdf9b5e0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/36180efea669/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/246eefaa06c6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/005d39b8b553/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/aaf6fdf9b5e0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/36180efea669/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffad/8487066/246eefaa06c6/gr5.jpg

相似文献

1
SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity.SARS-CoV-2 S2P 刺突通过不同状态的老化,改变了其免疫原性。
J Biol Chem. 2021 Oct;297(4):101127. doi: 10.1016/j.jbc.2021.101127. Epub 2021 Aug 27.
2
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection.在小鼠模型中观察到针对贝塔冠状病毒刺突蛋白的原始抗原性感染反应,但在儿童感染 SARS-CoV-2 后并不明显。
PLoS One. 2021 Aug 27;16(8):e0256482. doi: 10.1371/journal.pone.0256482. eCollection 2021.
3
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.SARS-CoV-2变异株与SARS-CoV交叉中和背后的B细胞基因组学
Cell. 2021 Jun 10;184(12):3205-3221.e24. doi: 10.1016/j.cell.2021.04.032. Epub 2021 Apr 24.
4
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中和抗体及合胞体调节的结构洞察。
Cell. 2021 Jun 10;184(12):3192-3204.e16. doi: 10.1016/j.cell.2021.04.033. Epub 2021 Apr 24.
5
SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses.SARS-CoV-2 蛋白亚单位疫苗接种于小鼠和恒河猴可诱导强烈且持久的中和抗体应答。
Cell Rep Med. 2021 Apr 20;2(4):100252. doi: 10.1016/j.xcrm.2021.100252. Epub 2021 Apr 5.
6
D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation.SARS-CoV-2 刺突蛋白中的 D614G 突变通过使病毒对温度依赖性变性脱敏来增强病毒适应性。
J Biol Chem. 2021 Oct;297(4):101238. doi: 10.1016/j.jbc.2021.101238. Epub 2021 Sep 24.
7
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.昆虫细胞表达的 SARS-CoV-2 刺突蛋白可在非人灵长类动物中引起高中和抗体滴度。
Emerg Microbes Infect. 2020 Dec;9(1):2076-2090. doi: 10.1080/22221751.2020.1821583.
8
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice.佐剂化的 SARS-CoV-2 刺突蛋白在小鼠单次免疫后可引发中和抗体和 CD4 T 细胞应答。
EBioMedicine. 2021 Jan;63:103197. doi: 10.1016/j.ebiom.2020.103197. Epub 2021 Jan 7.
9
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.破坏融合前刺突中和 SARS-CoV-2。
Cell Host Microbe. 2020 Sep 9;28(3):445-454.e6. doi: 10.1016/j.chom.2020.06.010. Epub 2020 Jun 19.
10
Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2.基于水凝胶的受体结合域亚单位疫苗的缓慢释放可引发针对 SARS-CoV-2 的中和抗体应答。
Adv Mater. 2021 Dec;33(51):e2104362. doi: 10.1002/adma.202104362. Epub 2021 Oct 14.

引用本文的文献

1
S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines.德尔塔和奥密克戎变异株刺突蛋白中的S6P突变显著提高了新冠mRNA疫苗的效力。
Front Immunol. 2025 Jan 3;15:1495561. doi: 10.3389/fimmu.2024.1495561. eCollection 2024.
2
Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster models.工程蛋白亚单位 COVID19 疫苗在小鼠和仓鼠模型中与纳米颗粒一样具有免疫原性。
Sci Rep. 2024 Oct 26;14(1):25528. doi: 10.1038/s41598-024-76377-y.
3
Assessing pH-Dependent Conformational Changes in the Fusion Peptide Proximal Region of the SARS-CoV-2 Spike Glycoprotein.

本文引用的文献

1
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.mRNA-1273 疫苗对非人灵长类动物中 SARS-CoV-2 的免疫保护相关性。
Science. 2021 Sep 17;373(6561):eabj0299. doi: 10.1126/science.abj0299.
2
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.健康成年人中新型冠状病毒重组蛋白疫苗制剂的安全性和免疫原性:一项随机、安慰剂对照、1-2 期、剂量范围研究的中期结果。
Lancet Infect Dis. 2021 Sep;21(9):1257-1270. doi: 10.1016/S1473-3099(21)00147-X. Epub 2021 Apr 19.
3
评估 SARS-CoV-2 刺突糖蛋白融合肽近端区域的 pH 依赖性构象变化。
Viruses. 2024 Jul 2;16(7):1066. doi: 10.3390/v16071066.
4
Analytical Ultracentrifugation Detects Quaternary Rearrangements and Antibody-Induced Conformational Selection of the SARS-CoV-2 Spike Trimer.分析超速离心检测 SARS-CoV-2 刺突三聚体的四级重排和抗体诱导的构象选择。
Int J Mol Sci. 2023 Oct 3;24(19):14875. doi: 10.3390/ijms241914875.
5
Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates.大量 SARS-CoV-2 刺突三聚体疫苗抗原候选物的变体特异性突变、温度和 pH 值对构象的影响。
Sci Rep. 2023 Oct 1;13(1):16498. doi: 10.1038/s41598-023-43661-2.
6
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery.自组装的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白-乙肝表面抗原(spike-HBsAg)纳米颗粒通过基因递送引发强效且持久的中和抗体反应。
NPJ Vaccines. 2023 Aug 8;8(1):111. doi: 10.1038/s41541-023-00707-w.
7
Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域的构象动力学
Biomedicines. 2022 Dec 12;10(12):3233. doi: 10.3390/biomedicines10123233.
8
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.用于对抗SARS-CoV-2的纳米材料:预防、诊断和治疗新冠肺炎的策略。
Front Bioeng Biotechnol. 2022 Nov 25;10:1052436. doi: 10.3389/fbioe.2022.1052436. eCollection 2022.
9
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins.DARPins 对 SARS-CoV-2 关切变异株的强大且广泛的中和作用。
Nat Chem Biol. 2023 Mar;19(3):284-291. doi: 10.1038/s41589-022-01193-2. Epub 2022 Nov 21.
10
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.mRNA-1273 或 Omicron 加强针在接种疫苗的猕猴中引发相似的 B 细胞扩增、中和反应,并提供针对 Omicron 的保护。
Cell. 2022 Apr 28;185(9):1556-1571.e18. doi: 10.1016/j.cell.2022.03.038. Epub 2022 Mar 25.
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.
中和抗体LY-CoV555可保护非人类灵长类动物免受SARS-CoV-2感染。
Sci Transl Med. 2021 May 12;13(593). doi: 10.1126/scitranslmed.abf1906. Epub 2021 Apr 5.
4
Cold sensitivity of the SARS-CoV-2 spike ectodomain.SARS-CoV-2 刺突蛋白胞外域的冷敏感性。
Nat Struct Mol Biol. 2021 Feb;28(2):128-131. doi: 10.1038/s41594-020-00547-5. Epub 2021 Jan 5.
5
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.REGN-COV2,一种中和抗体鸡尾酒疗法,用于治疗门诊新冠患者。
N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17.
6
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.SARS-CoV-2 刺突蛋白无 ACE2 和有 ACE2 的冷冻电镜结构揭示了一种 pH 依赖性开关,可介导受体结合结构域在内涵体中的定位。
Cell Host Microbe. 2020 Dec 9;28(6):867-879.e5. doi: 10.1016/j.chom.2020.11.004. Epub 2020 Nov 17.
7
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.NVX-CoV2373 疫苗可预防食蟹猴的上呼吸道和下呼吸道感染 SARS-CoV-2。
Vaccine. 2020 Nov 25;38(50):7892-7896. doi: 10.1016/j.vaccine.2020.10.064. Epub 2020 Oct 23.
8
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.工程化 ACE2 受体陷阱能有效中和 SARS-CoV-2。
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28046-28055. doi: 10.1073/pnas.2016093117. Epub 2020 Oct 22.
9
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.基于结构的设计结合基于标签的纯化和过程中生物素化可简化 SARS-CoV-2 刺突分子探针的开发。
Cell Rep. 2020 Oct 27;33(4):108322. doi: 10.1016/j.celrep.2020.108322. Epub 2020 Oct 12.
10
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.